Estrogen Receptor Mutation Study Suggests Potential Treatments For Endometrial Cancers
Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.
Stay updated with breaking news from Jay Gertz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.
Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.
Huntsman Cancer Institute researchers studied estrogen receptor mutations and its connections to endometrial cancer. The findings led to the identification of potential personalized treatments for a cancer with limited options.
Ligand Reports First Quarter 2021 Financial Results Search jobs Conference Call Begins at 4:30 p.m. Eastern Time Today SAN DIEGO--(BUSINESS WIRE)--$LGND#earnings-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2021 and provided an operating forecast and program updates. Ligand management will host a conference call today beginning at 4:30 p.m. Eastern time to discuss this announcement and answer questions. “This year has opened strong for Ligand with solid financial performance and great results from all of our core...